PRECLINICAL MECHANISTIC AND CLINICAL EVALUATION OF THE CORTICOSTEROID DEXAMETHASONE'S DETRIMENTAL EFFECTS ON IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA CANCER

被引：0
|
作者：
Iorgulescu, Bryan [1 ]
Gokhale, Prafulla [1 ]
Speranza, Maria [1 ]
Eschle, Benjamin [1 ]
Poitras, Michael [1 ]
Wilkens, Margaret [1 ]
Soroko, Kara [1 ]
Chhoeu, Chhayheng [1 ]
Knott, Aine [1 ]
Gao, Yan [1 ]
Lim-Fat, Mary Jane [1 ]
Baker, Gregory [2 ]
Bonal, Dennis [1 ]
Quang-De Nguyen [1 ]
Grant, Gareth [1 ]
Ligon, Keith
Sorger, Peter [2 ]
Chiocca, E. [3 ]
Anderson, Ana [3 ]
Kirschmeier, Paul [1 ]
Sharpe, Arlene [2 ]
Freeman, Gordon [1 ]
Reardon, David [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] BWH, Boston, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
209
引用
收藏
页码：A123 / A126
页数：4
相关论文
共 50 条
  • [1] Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
    Iorgulescu, J. Bryan
    Gokhale, Prafulla C.
    Speranza, Maria C.
    Eschle, Benjamin K.
    Poitras, Michael J.
    Wilkens, Margaret K.
    Soroko, Kara M.
    Chhoeu, Chhayheng
    Knott, Aine
    Gao, Yan
    Lim-Fat, Mary Jane
    Baker, Gregory J.
    Bonal, Dennis M.
    Nguyen, Quang-De
    Grant, Gareth R. L.
    Ligon, Keith L.
    Sorger, Peter K.
    Chiocca, E. Antonio
    Anderson, Ana C.
    Kirschmeier, Paul T.
    Sharpe, Arlene H.
    Freeman, Gordon J.
    Reardon, David A.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (01) : 276 - 287
  • [2] CONCURRENT DEXAMETHASONE LIMITS THE CLINICAL BENEFIT OF IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA
    Iorgulescu, Bryan
    Gokhale, Prafulla
    Speranza, Maria
    Eschle, Benjamin
    Poitras, Michael
    Wilkens, Margaret
    Soroko, Kara
    Chhoeu, Chhayheng
    Knott, Aine
    Gao, Yang
    Lim-Fat, Mary Jane
    Baker, Gregory
    Bonal, Dennis
    Quang-De Nguyen
    Grant, Gareth
    Ligon, Keith
    Sorger, Peter
    Chiocca, E. Antonio
    Anderson, Ana
    Kirschmeier, Paul
    Sharpe, Arlene
    Freeman, Gordon
    Reardon, David
    [J]. NEURO-ONCOLOGY, 2020, 22 : 106 - 106
  • [3] Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
    Russell Maxwell
    Christopher M. Jackson
    Michael Lim
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [4] Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
    Maxwell, Russell
    Jackson, Christopher M.
    Lim, Michael
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (08)
  • [5] IMMUNE CHECKPOINT BLOCKADE FOR GLIOBLASTOMA: PRECLINICAL ACTIVITY OF SINGLE AGENT AND COMBINATORIAL THERAPY
    Reardon, David
    Gokhale, Prafulla
    Ligon, Keith
    Liao, Xiaoyun
    Rodig, Scott
    Zhou, Jun
    Qin, Lei
    Hodi, Stephen
    Jones, Kristen
    Sauer, Amy
    Kohl, Nancy
    Dranoff, Glenn
    Freeman, Gordon
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [6] IMMUNE CHECKPOINT BLOCKADE FOR GLIOBLASTOMA: PRECLINICAL ACTIVITY OF SINGLE AGENT AND COMBINATORIAL THERAPY
    Reardon, David A.
    Gokhale, Praful
    Ligon, Keith
    Liao, Xiaoyun
    Rodig, Scott
    Zhou, Jun
    Win, Lei
    Hodi, Frank S.
    Kohl, Nancy E.
    Freeman, Gordon
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [7] Immune checkpoint blockade for glioblastoma Preclinical activity of single agent and combinatorial therapy.
    Reardon, David A.
    Gokhale, Prafulla C.
    Hodl, F. Stephen
    Ligon, Keith L.
    Liao, Xiaoyun
    Rodig, Scott J.
    Zhou, Jun
    Qin, Lei
    Jones, Kristen
    Sauer, Amy
    Kohl, Nancy E.
    Dranoff, Glenn
    Freeman, Gordon James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer
    Borcherding, Nicholas
    Kolb, Ryan
    Gullicksrud, Jodi
    Vikas, Praveen
    Zhu, Yuwen
    Zhang, Weizhou
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2018, 430 (14) : 2014 - 2029
  • [9] Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma
    Speranza, Maria-Carmela
    Passaro, Carmela
    Ricklefs, Franz
    Kasai, Kazue
    Klein, Sarah R.
    Nakashima, Hiroshi
    Kaufmann, Johanna K.
    Ahmed, Abdul-Kareem
    Nowicki, Michal O.
    Obi, Prisca
    Bronisz, Agnieszka
    Aguilar-Cordova, Estuardo
    Aguilar, Laura K.
    Guzik, Brian W.
    Breakefield, Xandra
    Weissleder, Ralph
    Freeman, Gordon J.
    Reardon, David A.
    Wen, Patrick Y.
    Chiocca, E. Antonio
    Lawler, Sean E.
    [J]. NEURO-ONCOLOGY, 2018, 20 (02) : 225 - 235
  • [10] Immunological and clinical implications of immune checkpoint blockade in human cancer
    Kim, Hyung-Don
    Park, Su-Hyung
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (07) : 567 - 581
12345